The Hormone Balance Study

Start date

Sep 30th, Oct 04th, 21st

Remuneration

$4,700

8 nights, 1 follow up

Help Test a New Potential drug for the Treatment of Congenital Adrenal Hyperplasia (CAH)

This clinical study is evaluating a potential new drug for to treat Congenital Adrenal Hyperplasia. Congenital Adrenal Hyperplasia is a genetic condition that affects how the adrenal glands make important hormones. The study is a randomised, double-blind, placebo-controlled trial. The purpose of this study is to assess the safety and tolerability of a single dose in healthy men and women with a BMI of 18–32.

Express Your Interest

Schedule

Cohort 1.1

8 Night Stay

Check In

Sep 30th

Check Out

Oct 08th

1 appointment

Oct 22nd

Cohort 1.2

8 Night Stay

Check In

Oct 04th

Check Out

Oct 12th

1 appointment

Oct 26th

Cohort 2.1

8 Night Stay

Check In

Oct 21st

Check Out

Oct 29th

1 appointment

Nov 12th

To Qualify, You Must

Age

Be 18 to 55 years old

Gender

Both males or females

Physical Condition

Have no significant medical health conditions or allergies

Requirements

Have a BMI between 18 and 32kg/m2

Remuneration

$4,700

Help Test a New Treatment for Congenital Adrenal Hyperplasia (CAH)

Spots are limited. Find out if you qualify today!

Express Your Interest